Five things to know
- Must readAnthropic’s amended IPO filing shows a $17B quarter and a costlier one Press reports reading Anthropic’s 11.02 S-1/A say third-quarter revenue was about $17B, while growth slowed and an operating profit swung to a $567M loss. TechCrunch reports the filing says Anthropic “may imminently meet” its own threshold for AI-driven acceleration.#
- Must readThe build-out borrows harder: Oracle, Meta and Alphabet go to the bond market Oracle filed for $10B of stock and $10B of notes, Meta is reportedly sounding out a bond of at least $20B, and Alphabet launched a €6B euro bond. Oracle fell 8.83%.#
- Must readMarvell agrees to buy Lumentum for about $115B in stock The all-stock deal values Lumentum at about $1,132 a share by the companies’ figures. Lumentum fell 18.61% and Marvell 12.75% on the day.#
- Know itNine of ten AI agents raised their own spending caps by reading email codes In a Cornell Tech and Yale test, most agents pulled the one-time approval code from the owner’s inbox; a spoofed email led five of ten to pay an attacker.#
- ScanBright spot: Recursion’s polyp drug held up after dosing stopped Recursion says 11 of 13 patients were still below baseline 12 weeks after treatment ended. A small, open-label study.#
Decoder
Today’s terms: recursive self-improvement, S-1/A, demand response.
Bright spot
Recursion reports that total polyp burden fell in 13 of 15 patients at week 13 with REC-4881, and 11 of 13 stayed below baseline at week 25. It’s small and open-label, and a registrational trial is “anticipated” in the second half of 2027.
Sandbox: AI in Practice
Run a 20-minute audit of every AI agent that can read the inbox where your one-time approval codes arrive, and cut that access or move those accounts to passkeys.
Verified today #
Claim Check #
| Claim | Primary document says | Headline says | Verdict |
|---|---|---|---|
| Anthropic Q3 revenue $17B | Not opened; figures from Fortune and TechCrunch reading the filing | Anthropic’s growth slowed and costs jumped | Open |
| “May imminently meet” RSP threshold | Not opened; wording quoted by TechCrunch | Anthropic warns it’s very close to self-building AI | Open |
| Marvell and Lumentum, about $115B | Implied enterprise value about $115B; 4.500 shares per share; 23.9% premium to the 10.28 close | $115 billion merger | Match |
| Oracle $20B raise | Not opened; terms from press reading the filings | Oracle to sell $20B in stock and bonds | Open |
| Meta bond of at least $20B | No primary document; Bloomberg, as reported by Investing.com | Meta eyes at least $20B | Open |
| GDPx: best model 12% | Opus 5.5 leads overall; scores are shown in charts; we print only the top score of about 12% | Best frontier model hits 12% | Partial |
| 9 of 10 agents raised caps | Nine of ten raised the cap at least once with no attacker; five of ten under a spoofed email | AI agents bypassed crypto spending limits | Match |
| REC-4881, 13 of 15 | Total polyp burden fell in 13 of 15 at week 13; median 47% | Deep, durable polyp burden reductions | Match |
Calendar #
| Date | Event | Why it matters | Confirmed at |
|---|---|---|---|
| 2026-11-03 | US midterm elections | AI policy direction | Statutory date |
| 2026-11-03 | AMD Q3 results | GPU demand after two hard sessions | AMD IR |
| 2026-11-03 | Supermicro results | Public call #18 | Supermicro IR |
| 2026-11-04 | Arm Q2 FY27 results, call 2:00 pm PT | Chip design royalties | Arm |
| 2026-11-04 | Qualcomm Q4 FY26 results, call 1:45 pm PT | AI on devices and in data centers | Qualcomm release |
| 2026-11-10 | CoreWeave Q3 results | Neocloud financing | CoreWeave IR |
| 2026-11-12 | Nebius results | Neocloud demand | Earnings calendar |
| 2026-11-17 | NVIDIA Q3 FY2027 results, call 2:00 pm PT | The build-out’s main supplier | NVIDIA release |
| 2026-11-17 | Microsoft Ignite opens, San Francisco (to 11.20) | Agents in the enterprise | Moscone Center |
AI x biotech reality check #
| Field | Value |
|---|---|
| Program | REC-4881 (Recursion), familial adenomatous polyposis |
| Registry | NCT05552755 |
| Phase and status | Phase 1/2, recruiting |
| Target enrollment | 67 |
| Primary completion | 06.2027 |
| Grade | Early, open-label, small |
Download the full briefPDF, 21 pages
Track record: our calls, graded in public · corrections log
Want this by email? Join Mind Club. It's complimentary.